Understanding how novel medications and current pharmacogenetics research can enable better outcomes in schizophrenia will be the focus of the next Brain & Behavior Research Foundation monthly webinar on Tuesday, October 18, 2016 from 2 to 3 p.m. EST. Herbert Y. Meltzer, M.D., NARSAD Grantee, and professor of Psychiatry, Behavioral Sciences, Physiology, and Pharmacology at Northwestern Feinberg School of Medicine, will discuss the possible role of prodromal schizophrenia in shaping the seminal contributions “Beautiful Mind” mathematician John Nash gave to game theory, and how his son’s struggle with schizophrenia motivated Nash to seek and achieve partial functional recovery, while not taking antipsychotic medication.
The free webinar is open to the public, who can register online at bbrfoundation.org/webinars. During the last 15 minutes of the webinar, Dr. Meltzer will answer questions posed by participants.
This webinar is part of a monthly series in which Jeffrey Borenstein, M.D., president & CEO of the Brain & Behavior Research Foundation, hosts presentations by leading mental health researchers who discuss and answer questions about the latest in new technologies, early intervention strategies and next-generation therapies for brain and behavior disorders and mental illness. Each webinar is live tweeted with the hashtag #brainchat. After the live event, recordings of the webinars are available on the Foundation’s website at: bbrfoundation.org/webinar.
For more information: call 800-829-8289, or visit bbrfoundation.org.